Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 3
1980 1
1981 6
1982 3
1983 3
1984 3
1985 4
1986 4
1988 1
1989 3
1990 5
1991 2
1992 10
1993 7
1994 9
1995 4
1996 3
1997 3
1998 3
1999 3
2000 5
2001 5
2002 8
2003 6
2004 5
2005 4
2006 4
2007 7
2008 5
2009 7
2010 10
2011 11
2012 10
2013 8
2014 17
2015 14
2016 10
2017 18
2018 15
2019 11
2020 11
2021 6
2022 8
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Results by year

Filters applied: . Clear all
Page 1
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki K, Clingan PR, Lonardi S, Kim TW, Simms L, Chang SC, Nasroulah F; RAISE Study Investigators. Tabernero J, et al. Among authors: portnoy dc. Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12. Lancet Oncol. 2015. PMID: 25877855 Clinical Trial.
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial.
VanderWalde A, Bellasea SL, Kendra KL, Khushalani NI, Campbell KM, Scumpia PO, Kuklinski LF, Collichio F, Sosman JA, Ikeguchi A, Victor AI, Truong TG, Chmielowski B, Portnoy DC, Chen Y, Margolin K, Bane C, Dasanu CA, Johnson DB, Eroglu Z, Chandra S, Medina E, Gonzalez CR, Baselga-Carretero I, Vega-Crespo A, Garcilazo IP, Sharon E, Hu-Lieskovan S, Patel SP, Grossmann KF, Moon J, Wu MC, Ribas A. VanderWalde A, et al. Among authors: portnoy dc. Nat Med. 2023 Sep;29(9):2278-2285. doi: 10.1038/s41591-023-02498-y. Epub 2023 Aug 17. Nat Med. 2023. PMID: 37592104 Free PMC article. Clinical Trial.
Listeriolysin O: A phagosome-specific cytolysin revisited.
Nguyen BN, Peterson BN, Portnoy DA. Nguyen BN, et al. Among authors: portnoy da. Cell Microbiol. 2019 Mar;21(3):e12988. doi: 10.1111/cmi.12988. Epub 2019 Jan 15. Cell Microbiol. 2019. PMID: 30511471 Free PMC article. Review.
Strategies Used by Bacteria to Grow in Macrophages.
Mitchell G, Chen C, Portnoy DA. Mitchell G, et al. Among authors: portnoy da. Microbiol Spectr. 2016 Jun;4(3):10.1128/microbiolspec.MCHD-0012-2015. doi: 10.1128/microbiolspec.MCHD-0012-2015. Microbiol Spectr. 2016. PMID: 27337444 Free PMC article. Review.
Deficiency in Galectin-3, -8, and -9 impairs immunity to chronic Mycobacterium tuberculosis infection but not acute infection with multiple intracellular pathogens.
Morrison HM, Craft J, Rivera-Lugo R, Johnson JR, Golovkine GR, Bell SL, Dodd CE, Van Dis E, Beatty WL, Margolis SR, Repasy T, Shaker I, Lee AY, Vance RE, Stanley SA, Watson RO, Krogan NJ, Portnoy DA, Penn BH, Cox JS. Morrison HM, et al. Among authors: portnoy da. PLoS Pathog. 2023 Jun 23;19(6):e1011088. doi: 10.1371/journal.ppat.1011088. eCollection 2023 Jun. PLoS Pathog. 2023. PMID: 37352334 Free PMC article.
Listeriolysin O: a phagosome-specific lysin.
Schnupf P, Portnoy DA. Schnupf P, et al. Among authors: portnoy da. Microbes Infect. 2007 Aug;9(10):1176-87. doi: 10.1016/j.micinf.2007.05.005. Epub 2007 May 7. Microbes Infect. 2007. PMID: 17720603 Free article. Review.
Molecular determinants of Listeria monocytogenes pathogenesis.
Portnoy DA, Chakraborty T, Goebel W, Cossart P. Portnoy DA, et al. Infect Immun. 1992 Apr;60(4):1263-7. doi: 10.1128/iai.60.4.1263-1267.1992. Infect Immun. 1992. PMID: 1312514 Free PMC article. Review. No abstract available.
276 results